Cipher Pharmaceuticals Company Profile (NASDAQ:CPHR)

About Cipher Pharmaceuticals

Cipher Pharmaceuticals logoCipher Pharmaceuticals Inc. is a specialty pharmaceutical dermatology company. The Company has a portfolio of commercial and late-stage products. It operates in the specialty pharmaceuticals segment. It acquires products and compounds for treatment of various medical needs. Its commercial product portfolio includes ABSORICA; SITAVIG; NUVAIL; BIONECT; CLN8; INOVA; PRO:12 MOUSSE; AL12; LOTION UMECTA; ACLARO; EPURIS; VANIQA; ACTIKERALL; BETEFLAM; LIPOFEN; CONZIP, and DURELA. Its products treat indications, such as severe nodular acne, recurrent herpes labialis, nail dystrophy, dermal ulcers, mild/moderate onychomycosis, acne, dry skin, keratosis, hyperpigmentation, hyperkeratotic actinic keratosis and high cholesterol. Its pipeline of late-stage products includes DERMADEXIN, BETEFLAM PATCH, SITAVIG, PRURIDEXIN, OZENOXACIN, CF101 for plaque psoriasis, CF101 for rheumatoid arthritis, ASF-1096 and NANOLIPOLEE-007. It operates in Canada and the United States.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CPHR
  • CUSIP:
Key Metrics:
  • Previous Close: $2.99
  • 50 Day Moving Average: $2.9900
  • 200 Day Moving Average: $3.4826
  • 52-Week Range: $2.55 - $6.37
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 149.51
  • P/E Growth: 0.0000
  • Market Cap: $N/A
  • Beta: 1.39
Profitability:
  • Net Margins: -64.97%
  • Return on Equity: -9.83%
  • Return on Assets: -4.40%
Debt:
  • Debt-to-Equity Ratio: 1.22%
  • Current Ratio: 2.59%
  • Quick Ratio: 2.50%
Additional Links:
Companies Related to Cipher Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Cipher Pharmaceuticals (NASDAQ:CPHR) (?)
Ratings Breakdown: 2 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $3.50 (17.05% upside)

Analysts' Ratings History for Cipher Pharmaceuticals (NASDAQ:CPHR)
Show:
DateFirmActionRatingPrice TargetDetails
11/16/2016TD SecuritiesDowngradeBuy -> Hold$7.50 -> $3.50View Rating Details
8/13/2016GMP SecuritiesReiterated RatingHoldView Rating Details
11/30/2015CIBCInitiated CoverageSector Outperform -> Outperform$6.20View Rating Details
(Data available from 2/21/2015 forward)

Earnings

Earnings History for Cipher Pharmaceuticals (NASDAQ:CPHR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/11/2016Q316($0.07)($0.08)$10.42 million$9.30 millionViewN/AView Earnings Details
11/4/2015$0.07($0.04)ViewN/AView Earnings Details
8/14/2015$0.02$0.01ViewN/AView Earnings Details
5/13/2015Q115$0.17$0.10$7.88 million$9.18 millionViewN/AView Earnings Details
2/25/2015$0.12$0.12ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cipher Pharmaceuticals (NASDAQ:CPHR)
Current Year EPS Consensus Estimate: $-0.7700 EPS
Next Year EPS Consensus Estimate: $0.0200 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.04)($0.04)($0.04)
Q2 20161($0.02)($0.02)($0.02)
Q3 20161($0.10)($0.10)($0.10)
Q4 20161($0.03)($0.03)($0.03)
Q1 20171$0.03$0.03$0.03
Q2 20171$0.01$0.01$0.01
Q3 20171$0.01$0.01$0.01
Q4 20171($0.01)($0.01)($0.01)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cipher Pharmaceuticals (NASDAQ:CPHR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cipher Pharmaceuticals (NASDAQ:CPHR)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Cipher Pharmaceuticals (NASDAQ:CPHR)
DateHeadline
us.rd.yahoo.com logo6:30 am Cipher Pharma announces plans to voluntarily delist from Nasdaq (NASDAQ:CPHR)
us.rd.yahoo.com - November 30 at 4:33 PM
nasdaq.com logoArrowhead Blunted, CERC Depressed, It's All Clear For NOVN, CPHR Leaves Nasdaq (NASDAQ:CPHR)
www.nasdaq.com - November 30 at 9:26 AM
streetinsider.com logoCipher Pharma (CPHR) Will Delist from Nasdaq on Voluntary Basis (NASDAQ:CPHR)
www.streetinsider.com - November 30 at 9:26 AM
capitalcube.com logoCipher Pharmaceuticals Ltd. :CPHR-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016 (NASDAQ:CPHR)
www.capitalcube.com - November 30 at 9:26 AM
finance.yahoo.com logoCipher Pharmaceuticals Responds to Request for Comment from IIROC (NASDAQ:CPHR)
finance.yahoo.com - October 31 at 4:27 PM
streetinsider.com logoCipher Pharma (CPHR) Confirms It's Working with Advisor on Various Strategic Alternatives (NASDAQ:CPHR)
www.streetinsider.com - October 31 at 4:27 PM
finance.yahoo.com logoNotice of Cipher Pharmaceuticals Inc. Q3 2016 Conference Call (NASDAQ:CPHR)
finance.yahoo.com - October 27 at 4:43 PM
capitalcube.com logoCipher Pharmaceuticals Ltd.: Strong price momentum but will it sustain? (NASDAQ:CPHR)
www.capitalcube.com - October 20 at 9:48 PM
streetinsider.com logoCipher Pharma (CPHR) Names Stephen Lemieux as CFO (NASDAQ:CPHR)
www.streetinsider.com - September 2 at 9:09 AM
capitalcube.com logoCipher Pharmaceuticals Ltd. :CPHR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 18, 2016 (NASDAQ:CPHR)
www.capitalcube.com - August 18 at 4:23 PM
finance.yahoo.com logoCipher Pharmaceuticals Reports Q2 2016 Results Highlighted by 32% Revenue Growth and $3.1 Million Cash from Operations (NASDAQ:CPHR)
finance.yahoo.com - August 10 at 8:04 AM
finance.yahoo.com logoNotice of Cipher Pharmaceuticals Inc. Q2 2016 Conference Call (NASDAQ:CPHR)
finance.yahoo.com - July 20 at 12:00 PM
fxpips.com logoTrading Report: Manufacturing Stocks Gainers, Losers (NASDAQ:CPHR)
www.fxpips.com - July 14 at 8:31 AM
fxpips.com logoManufacturing Stocks Weekend Recap (NASDAQ:CPHR)
www.fxpips.com - July 9 at 5:59 AM
finance.yahoo.com logoSpecial Committee of Cipher Pharmaceuticals Responds to Early Warning Report Filed by 1207407 Ontario Limited (NASDAQ:CPHR)
finance.yahoo.com - July 6 at 10:00 AM
fxpips.com logoManufacturing Stocks Gainers and Losers (NASDAQ:CPHR)
www.fxpips.com - June 21 at 9:06 AM
investors.com logoEdesa Biotech licenses skin disorder treatment from Cipher (NASDAQ:CPHR)
www.proactiveinvestors.com - June 21 at 9:06 AM
finance.yahoo.com logoCipher Pharmaceuticals to Present at Two Upcoming U.S. Investor Conferences (NASDAQ:CPHR)
finance.yahoo.com - May 31 at 10:00 AM
fxpips.com logoPrice Advance – ATRM, CPHR, GBR, CCXI, TCX, PFNX, NVFY (NASDAQ:CPHR)
www.fxpips.com - May 19 at 11:54 AM
capitalcube.com logoCipher Pharmaceuticals Ltd. :CPHR-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:CPHR)
www.capitalcube.com - May 11 at 11:29 AM
News IconCalgary indie pop act Lab Coast ready to deliver on all expectations (NASDAQ:CPHR)
www.theprovince.com - May 5 at 10:56 AM
News IconCipher Pharmaceuticals posts first-quarter loss of $2.7 million (NASDAQ:CPHR)
www.brandonsun.com - May 5 at 10:56 AM
streetinsider.com logoCipher Pharma (CPHR) Licenses Global Rights to Dalhousie University's Investigational Tattoo Removal Cream (NASDAQ:CPHR)
www.streetinsider.com - May 3 at 10:44 AM
streetinsider.com logoCipher Pharma (CPHR) Licenses Global Rights to Dalhousie University's Investigational Tattoo Removal Cream - StreetInsider.com (NASDAQ:CPHR)
www.streetinsider.com - May 2 at 11:37 AM
investornewswire.com logoCipher Pharmaceuticals Inc. (NASDAQ:CPHR) Has An Average Rating Of 4 - Investor Newswire (NASDAQ:CPHR)
www.investornewswire.com - April 24 at 10:28 AM
streetinsider.com logoCipher Pharma's (CPHR) CFO Norm Evans to Retire (NASDAQ:CPHR)
www.streetinsider.com - April 24 at 10:28 AM
streetinsider.com logoCipher Pharma's (CPHR) CFO Norm Evans to Retire - StreetInsider.com (NASDAQ:CPHR)
www.streetinsider.com - April 23 at 10:38 AM
clintongazette.com logoCipher Pharmaceuticals Incorporated (NASDAQ:CPHR) Shorted Shares Decreased By 0.25% - Clinton Financial (NASDAQ:CPHR)
www.clintongazette.com - April 16 at 10:33 AM
News IconCipher Pharmaceuticals Inc. (CPHR) Coverage Initiated by Analysts at TD Securities - Washington News Wire (NASDAQ:CPHR)
washingtonnewswire.com - April 13 at 10:48 AM
finance.yahoo.com logoCoverage initiated on Cipher Pharma by TD Securities (NASDAQ:CPHR)
finance.yahoo.com - April 13 at 9:07 AM
News IconCould Cipher Pharmaceuticals Inc See a Reversal After Having Formed Several Months Ascending Triangle Chart ... - Stock Caller (NASDAQ:CPHR)
www.stockcaller.com - April 12 at 10:22 AM
streetinsider.com logoCipher Pharma's (CPHR) Dermadexin and Pruridexin Approved in Canada (NASDAQ:CPHR)
www.streetinsider.com - April 7 at 10:27 AM
streetinsider.com logoCipher Pharma (CPHR) Launches Actikerall in Canada (NASDAQ:CPHR)
www.streetinsider.com - February 23 at 8:53 AM
streetinsider.com logoCipher Pharma (CPHR) Sitavig NDA Accepted for Review by Health Canada (NASDAQ:CPHR)
www.streetinsider.com - February 18 at 8:51 AM
finance.yahoo.com logo7:02 am Cipher Pharma announces review acceptance by Health Canada for Sitavig (NASDAQ:CPHR)
finance.yahoo.com - February 16 at 7:02 AM
finance.yahoo.com logoStoneCastle's Bruce Campbell Interviewed by The Life Sciences Report (NASDAQ:CPHR)
finance.yahoo.com - February 4 at 1:30 PM
finance.yahoo.com logoCipher Pharmaceuticals Inc. (CPHR) (NASDAQ:CPHR)
finance.yahoo.com - January 23 at 5:22 PM
finance.yahoo.com logoEuro Pacific Canada's Doug Loe Interviewed by The Life Sciences Report (NASDAQ:CPHR)
finance.yahoo.com - January 15 at 9:00 AM
finance.yahoo.com logoSanta Brings FDA and Health Canada Approvals for New Dermatology Products (NASDAQ:CPHR)
finance.yahoo.com - December 21 at 9:45 AM
finance.yahoo.com logoNotice of Cipher Pharmaceuticals Inc. Q3 2015 Conference Call (NASDAQ:CPHR)
finance.yahoo.com - October 21 at 8:30 AM
finance.yahoo.com logoCipher announces settlement in patent litigation for Absorica® (NASDAQ:CPHR)
finance.yahoo.com - October 5 at 7:00 AM
finance.yahoo.com logoCPHR: Product Sales Picked Up Steam in Second Quarter of 2015 (NASDAQ:CPHR)
finance.yahoo.com - August 21 at 11:25 AM

Social

What is Cipher Pharmaceuticals' stock symbol?

Cipher Pharmaceuticals trades on the NASDAQ under the ticker symbol "CPHR."

Where is Cipher Pharmaceuticals' stock going? Where will Cipher Pharmaceuticals' stock price be in 2017?

2 analysts have issued 1-year price objectives for Cipher Pharmaceuticals' shares. Their forecasts range from $3.50 to $3.50. On average, they anticipate Cipher Pharmaceuticals' stock price to reach $3.50 in the next year.

How do I buy Cipher Pharmaceuticals stock?

Shares of Cipher Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Cipher Pharmaceuticals stock cost?

One share of Cipher Pharmaceuticals stock can currently be purchased for approximately $2.99.

Cipher Pharmaceuticals (NASDAQ:CPHR) Chart for Tuesday, February, 21, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Cipher Pharmaceuticals (NASDAQ:CPHR)

Earnings History Chart

Earnings by Quarter for Cipher Pharmaceuticals (NASDAQ:CPHR)

Dividend History Chart

Dividend Payments by Quarter for Cipher Pharmaceuticals (NASDAQ:CPHR)

Last Updated on 2/21/2017 by MarketBeat.com Staff